Glaukos Sets New Chief Medical Officer

San Clemente-based Glaukos Corporation, which is developing medical technology for the treatment of glaucoma, saysi t has named L. Jay Katz, MD, FACS, as its new Chief Medical Officer. The company said that Katz is a practicing ophthalmologist, the Director of Glaucoma Service at Wills Eye Hospital in Philadelphia and a Professor of Ophthalmology at Jefferson Medical College at Thomas Jefferson University. The company said Katz was a former medical monitor for its various clinical trials.